3 Comments
author

Of course, all the above strongly supports the priority testing for HERV-K102 particle production, proviral genomic integration (conducted on genomic DNA sloughed into plasma), HERV-K102 envelope specific antibody and T cells in the prevention and recovery from SARS-CoV-2 infections particularly since increased proviral genomic integration was associated with sterilizing immunity for another RNA virus pandemic virus, HIV-1 (Laderoute M et al., Open AIDS J, 2015).

Expand full comment
author

In order to reduce the risk of immunosenescence in causing vaccine-related morbidity and/or mortality, vaccine recipients should be screened for immunosenescence and treated prior to administration of vaccines. These high risk individuals should receive this treatment for the duration of the pandemic. Protocols might use zinc and flavonoids in simple cases whereas others may need additional alpha-fetoprotein antagonists (Laderoute M, Discovery Medicine, 2015, 2020). Screening for immunosenescence could be as simple as blood pressure measurements.

Expand full comment

Nice to see a Canadian giving the truth,thanks.

Expand full comment